Updated guidelines for the management of Parlcinson's disease

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Kailash Bhatia, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust
  • ,
  • David J. Brooks
  • David J. Burn, Newcastle General Hospital
  • ,
  • Carl E. Clarke, City Hospital NHS Trust and University of Birmingham
  • ,
  • Donald G. Grosset, Institute of Neurological Sciences
  • ,
  • Douglas G. MacMahon, Plymouth University
  • ,
  • Jeremy Play Fer, University of Liverpool
  • ,
  • Anthony H.V. Schapira, Clinical Neurosciences in the University
  • ,
  • David Stewart, University College Medical School
  • ,
  • Adrian C. Williams, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London

New data on diagnosis, drug therapy, surgery and psychosocial concerns have emerged since the publication of the 1998 Guidelines for the Management of Parkinson's Disease. This article reviews new data and addresses issues left unanswered in the previous guidelines.

Original languageEnglish
JournalHospital Medicine
Volume62
Issue8
Pages (from-to)456-470
Number of pages15
ISSN1462-3935
DOIs
Publication statusPublished - 1 Jan 2001

See relations at Aarhus University Citationformats

ID: 131704678